Literature DB >> 17118789

Characterization of monoclonal antibodies directed against the rat neurotensin receptor NTS1.

Ronald T Niebauer1, Jim F White, Zhizhong Fei, Reinhard Grisshammer.   

Abstract

G protein-coupled receptors (GPCRs) are integral membrane proteins that mediate cellular responses to a variety of ligands and represent major drug targets. Despite their medical importance, detailed structural information is limited because only one GPCR has been crystallized and its structure determined. To develop tools to aid in the formation of well-ordered crystals, we generated monoclonal antibodies with high affinity to the rat neurotensin receptor. All antibodies bound to the C-terminus of the receptor, which may reflect the selection strategy used to identify high-affinity binders. Further characterization revealed that some antibodies bound to the receptor in a sodium chloride sensitive manner, but others did not. Epitope mapping revealed distinct antigenic regions within the receptor C-terminus. Tight binding of Fab fragments to the receptor was verified by size exclusion chromatography.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17118789     DOI: 10.1080/10799890600928228

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  3 in total

1.  Production and characterization of monoclonal antibodies sensitive to conformation in the 5HT2c serotonin receptor.

Authors:  Filippo Mancia; Susan Brenner-Morton; Risa Siegel; Zahra Assur; Yonghua Sun; Ira Schieren; Monica Mendelsohn; Richard Axel; Wayne A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

2.  Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Authors:  Franck Talmont; Lionel Moulédous
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-24       Impact factor: 3.000

3.  Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.

Authors:  Julie A Douthwaite; Sudharsan Sridharan; Catherine Huntington; Jayne Hammersley; Rose Marwood; Jonna K Hakulinen; Margareta Ek; Tove Sjögren; David Rider; Cyril Privezentzev; Jonathan C Seaman; Peter Cariuk; Vikki Knights; Joyce Young; Trevor Wilkinson; Matthew Sleeman; Donna K Finch; David C Lowe; Tristan J Vaughan
Journal:  MAbs       Date:  2015       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.